HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL (University College London) ...
Jan 28, 2016
0
33
Recent research has yielded new information about immune responses associated with—and potentially responsible for—protection from HIV infection, providing leads for new strategies to develop an HIV vaccine. Results from ...
Oct 21, 2015
0
43
Most HIV epidemics are still dominated by the first strain that entered a particular population. New research published in PLOS Computational Biology offers an explanation of why the global mixing of HIV variants is so slow.
Feb 5, 2015
0
10
An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the ...
Sep 3, 2014
0
0
A rare case of suspected HIV transmission from one woman to another was reported Thursday by US health authorities.
Mar 13, 2014
0
0
NIH-funded scientists have shown that boosting the production of certain broadly neutralizing antibodies can protect humanized mice from both intravenous and vaginal infection with HIV. Humanized mice have immune systems ...
Feb 11, 2014
0
0
A recently discovered HIV strain leads to significantly faster development of AIDS than currently prevalent forms, according to new research from Lund University in Sweden.
Nov 27, 2013
0
0
(HealthDay)—The first rapid test to detect the HIV-1 antigen, as well as blood antibodies for the HIV-1 and HIV-2 strains, has been approved by the U.S. Food and Drug Administration.
Aug 9, 2013
0
0
More than 1 in 270 people in the US are living with HIV and every 9.5 minutes someone is else is infected. The economic cost estimates associated with HIV/AIDS exceed 36 billion dollars a year. The development of effective ...
Apr 21, 2013
0
0
Decades of research and three large-scale clinical trials have so far failed to yield an effective HIV vaccine, in large part because the virus evolves so rapidly that it can evade any vaccine-induced immune response.
Mar 21, 2013
0
0
